Lakefront Biotherapeutics NV SEC filings LKFT
Lakefront Biotherapeutics NV has 545 filings in SEC EDGAR's recent list, going back to Nov 14, 2007. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 29, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 28, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 19, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 10, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 8, 2024 | — |
| SC 13D | Ownership over 5% (active) | Aug 23, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 2, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jun 7, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 3, 2022 | — |
| SC 13D | Ownership over 5% (active) | Nov 2, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 10, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 27, 2020 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 1, 2019 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 29, 2019 | — |
| SC 13D | Ownership over 5% (active) | Jul 23, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 17, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Jan 10, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 23, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 12, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 8, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2018 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 15, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2017 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 10, 2016 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Jan 27, 2016 | — |
| SC 13G | Ownership over 5% (passive) | Jun 18, 2015 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LKFT (Nasdaq), GLPGF (OTC)
- Incorporated in
- Belgium
- Headquarters
- 2800 Mechelen
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1421876
- Former names
- GALAPAGOS NV (until May 6, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.